BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9165561)

  • 1. Early switch from intravenous to oral antibiotics in hospitalized patients with infections: a 6-month prospective study.
    Ahkee S; Smith S; Newman D; Ritter W; Burke J; Ramirez JA
    Pharmacotherapy; 1997; 17(3):569-75. PubMed ID: 9165561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of unnecessary i.v. antibiotic days using general criteria for antibiotic switch.
    Waagsbø B; Sundøy A; Paulsen EQ
    Scand J Infect Dis; 2008; 40(6-7):468-73. PubMed ID: 18584533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Early change from intravenous to oral antibiotics: 'switch therapy'].
    Sevinç F; Prins JM; Koopmans RP; Langendijk PN; Dankert J; Speelman P
    Ned Tijdschr Geneeskd; 1999 Nov; 143(47):2364-9. PubMed ID: 10590775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early switch to oral antibiotics and early discharge guidelines in the management of community-acquired pneumonia.
    Lee RW; Lindstrom ST
    Respirology; 2007 Jan; 12(1):111-6. PubMed ID: 17207035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia.
    Ramirez JA; Srinath L; Ahkee S; Huang A; Raff MJ
    Arch Intern Med; 1995 Jun; 155(12):1273-6. PubMed ID: 7778957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In-hospital observation after antibiotic switch in pneumonia: a national evaluation.
    Nathan RV; Rhew DC; Murray C; Bratzler DW; Houck PM; Weingarten SR
    Am J Med; 2006 Jun; 119(6):512.e1-7. PubMed ID: 16750965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral and i.v.-to-p.o. switch antibiotic therapy of hospitalized patients with serious infections.
    Cunha BA
    Scand J Infect Dis; 2008; 40(11-12):1004-6. PubMed ID: 18821274
    [No Abstract]   [Full Text] [Related]  

  • 9. Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trial.
    Hidalgo M; Hornedo J; Lumbreras C; Trigo JM; Colomer R; Perea S; Gómez C; Ruiz A; García-Carbonero R; Cortés-Funes H
    Cancer; 1999 Jan; 85(1):213-9. PubMed ID: 9921995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration and route of antibiotic therapy in community-acquired pneumonia: switch and step-down therapy.
    Cassiere HA; Fein AM
    Semin Respir Infect; 1998 Mar; 13(1):36-42. PubMed ID: 9543474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How short can courses be in lower respiratory tract infections?
    Siegel R
    J Int Med Res; 2000; 28 Suppl 1():37A-47A. PubMed ID: 11092228
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment with sequential intravenous or oral moxifloxacin was associated with faster clinical improvement than was standard therapy for hospitalized patients with community-acquired pneumonia who received initial parenteral therapy.
    Welte T; Petermann W; Schürmann D; Bauer TT; Reimnitz P;
    Clin Infect Dis; 2005 Dec; 41(12):1697-705. PubMed ID: 16288390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of exclusively oral antibiotic therapy in patients hospitalized with nonsevere community-acquired pneumonia: a retrospective study and meta-analysis.
    Marras TK; Nopmaneejumruslers C; Chan CK
    Am J Med; 2004 Mar; 116(6):385-93. PubMed ID: 15006587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new approach to treatment of resistant gram-positive infections: potential impact of targeted IV to oral switch on length of stay.
    Desai M; Franklin BD; Holmes AH; Trust S; Richards M; Jacklin A; Bamford KB
    BMC Infect Dis; 2006 Jun; 6():94. PubMed ID: 16762061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibiotic streamlining: development and justification of an antibiotic streamlining program.
    Ramirez JA
    Pharm Pract Manag Q; 1996 Oct; 16(3):19-34. PubMed ID: 10166232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral step-down therapy is comparable to intravenous therapy for Staphylococcus aureus osteomyelitis.
    Daver NG; Shelburne SA; Atmar RL; Giordano TP; Stager CE; Reitman CA; White AC
    J Infect; 2007 Jun; 54(6):539-44. PubMed ID: 17198732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of complicated shunt infections: a clinical report.
    James HE; Bradley JS
    J Neurosurg Pediatr; 2008 Mar; 1(3):223-8. PubMed ID: 18352767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of sequential intravenous-to-oral antibiotic switch therapy in hospitalized patients with gram-positive infection: the SEQUENCE cohort study.
    Rodriguez-Pardo D; Pigrau C; Campany D; Diaz-Brito V; Morata L; de Diego IC; Sorlí L; Iftimie S; Pérez-Vidal R; García-Pardo G; Larrainzar-Coghen T; Almirante B
    Eur J Clin Microbiol Infect Dis; 2016 Aug; 35(8):1269-76. PubMed ID: 27180242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preventing prolonged antibiotic therapy by active implementation of switch guidelines].
    Handoko KB; van Asselt GJ; Overdiek JW
    Ned Tijdschr Geneeskd; 2004 Jan; 148(5):222-6. PubMed ID: 14983578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Community acquired pneumonia: from intravenous to oral cephalosporin sequential therapy].
    Fernández P; San Martín L
    Rev Med Chil; 2000 Mar; 128(3):267-72. PubMed ID: 10962867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.